NAC elevates intracellular GSH, suppresses H 2 O 2 accumulation, and blocks the NLRP3-CASP1-GSDMD pathway in vitro and in vivo 59-61
Medication isn't the only tool the State Health Plan is considering to help members lose weight and keep it off
But the pill versions tend to lead to less weight loss than the weekly injections a gap that could make them less appealing to patients
Nausea Vomiting Diarrhea Constipation Decreased appetite Injection-site reactions Gallbladder events (cholelithiasis, cholecystitis) reported in some Phase 2 participants Increased heart rate Possible pancreatitis (per GLP-1 class data not specifically reported in retatrutide trials) Frequently asked questions Is retatrutide FDA-approved
While existing pharmaceutical agents offer potential for mitigating DIC, more extensive clinical data is needed
Unlike traditional HGH therapy, AOD 9604 does not affect blood sugar or IGF-1 levels, making it safer for long-term use